Herzliya, Israel

Amnon Gonenne

This inventor holds 1 USPTO granted patent. Top assignee: Bio-Technology General Corporation. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Amnon Gonenne. Retrieved from https://idiyas.com/inventor/amnon-gonenne-ccu68z1p

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 90(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Amnon Gonenne: Innovator in Therapeutic SOD Compositions

Introduction

Amnon Gonenne is a notable inventor based in Herzliya, Israel. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic compositions that utilize superoxide dismutase (SOD).

Latest Patents

Gonenne holds a patent for "Therapeutic SOD compositions and uses thereof." This patent focuses on improved methods for the production of recombinant human superoxide dismutase and its analogs. These compositions are designed to catalyze the reduction of superoxide radicals, which can prevent or treat injuries caused by the presence of such radicals.

Career Highlights

Amnon Gonenne has dedicated his career to advancing biotechnological solutions. His work has been instrumental in developing methods that enhance the efficacy of therapeutic agents. He is currently associated with Bio-Technology General Corporation, where he continues to innovate in the field.

Collaborations

Gonenne collaborates with Marian Gorecki, contributing to the advancement of their shared goals in biotechnology. Their partnership exemplifies the collaborative spirit that drives innovation in this field.

Conclusion

Amnon Gonenne's work in therapeutic SOD compositions highlights his commitment to improving health outcomes through innovative biotechnology. His contributions are paving the way for new treatments that address critical health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…